By C. James Watson , Genevra L. Stone, Daniel L. Overbeek1, Takuyo Chiba & Michele M. Burns

The rules of fair play in sport generally prohibit the use of performance-enhancing drugs (PEDs). The World Anti-Doping Agency (WADA)

oversees global antidoping regulations and testing for elite athletes participating in Olympic sports. Efforts to enforce anti doping policies are complicated by the diverse and evolving compounds and strate gies employed by athletes to gain a competitive edge. Now between the uniquely proximate 2021 Tokyo and 2022 Beijing Olympic Games, we discuss WADA’s efforts to prevent PED use during the modern Olympic Games. Then, we review the major PED classes with a focus on pathophysiology, complexities of antidoping testing, and relevant toxicitiies. Providers from diverse practice environments are likely to care for patients using PEDs for a vari ety of reasons and levels of sport; these providers should be aware of common PED classes and their risks.

Journal of Internal Medicine, Volume291, Issue2, 2022

By Karen Otis, Alejandra Garcia, Taylor DeClerck, Preeti Menon, Zephi Francis, and Matthew Collinson

The criminal legal system has a well-documented history of racial disparities and mistreatment of minoritized racial and ethnic groups. Treatment courts are a part of this same system and unfortunately, have not been exempt from racial and ethnic disparities in its programs. American University and the Center for Justice Innovation collaborated to assist treatment courts in several states in tackling racial and ethnic disparities. This report outlines results and policy recommendations derived from American University’s and the Center for Justice Innovation’s racial and ethnic disparities statewide training and technical assistance collaboration.

New York: Center for Justice Innovation. 2024, 16pg